[Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
Ovarian cancer treatment on the standpoint of the gynecologic oncologist: Ovarian cancer is comprehensively treated with combined surgery and anticancer chemotherapy, which influence each other. In the initial surgery, a cancer stage is decided, and in advanced cancer, primary debulking surgery is conducted. The outcome of postoperative chemotherapy has a correlation with the diameter of the postoperative residual tumor. Recently, a new treatment strategy of interval debulking surgery during chemotherapy has been widely conducted to completely remove tumors. Improved diagnostic imaging such as PET enhances aggressive surgery for recurrent cancer.
Sugiyama
Toru
T
Dept. of Obstetrics and Gynecology, Iwate Medical University School of Medicine.
Yoshizaki
Akira
A
Hatayama
Shinya
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D013509:Gynecologic Surgical Procedures / Q000379:methods; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D007258:Informed Consent; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000601:surgery; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D017239:Paclitaxel / Q000008:administration & dosage; D015996:Survival Rate; D043823:Taxoids / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage
D043823:Taxoids; D001761:Bleomycin; D014747:Vinblastine; D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin